CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-21 | Llado George Sr. Director | Grant or award | +946 | $134.98 | $128K | 4,295 |
| 2025-05-21 | Llado George Sr. Director | Grant or award | +519 | $134.98 | $70K | 4,814 |
| 2025-05-21 | Llado George Sr. Director | Grant or award · Stock Options (Right to Buy) | +2,076 | $134.98 | $280K | 2,076 |
| 2025-05-21 | MACKAY MARTIN Director | Grant or award | +946 | $134.98 | $128K | 13,477 |
| 2025-05-21 | MACKAY MARTIN Director | Grant or award | +815 | $134.98 | $110K | 14,292 |
| 2025-05-21 | MACKAY MARTIN Director | Grant or award · Stock Options (Right to Buy) | +2,076 | $134.98 | $280K | 2,076 |
| 2025-05-21 | Kemps-Polanco Reshema Director | Grant or award | +946 | $134.98 | $128K | 1,960 |
| 2025-05-21 | Kemps-Polanco Reshema Director | Grant or award | +630 | $134.98 | $85K | 2,590 |
| 2025-05-21 | Kemps-Polanco Reshema Director | Grant or award · Stock Options (Right to Buy) | +2,076 | $134.98 | $280K | 2,076 |
| 2025-05-21 | WILSON VIRGINIA M Director | Grant or award | +946 | $134.98 | $128K | 4,911 |
| 2025-05-21 | WILSON VIRGINIA M Director | Grant or award · Stock Options (Right to Buy) | +2,076 | $134.98 | $280K | 2,076 |
| 2025-05-21 | Andrews Nancy C Director | Grant or award | +946 | $134.98 | $128K | 3,964 |
| 2025-05-21 | Andrews Nancy C Director | Grant or award · Stock Options (Right to Buy) | +2,076 | $134.98 | $280K | 2,076 |
| 2025-05-15 | MASSARO GEORGE Director | Sale 10b5-1 | −35 | $136.32 | $5K | 5,680 |
| 2025-05-15 | MASSARO GEORGE Director | Sale 10b5-1 | −81 | $137.68 | $11K | 5,599 |
| 2025-05-15 | MASSARO GEORGE Director | Sale 10b5-1 | −24 | $139.05 | $3K | 5,575 |
| 2025-05-14 | MASSARO GEORGE Director | Sale 10b5-1 | −91 | $139.95 | $13K | 5,764 |
| 2025-05-14 | MASSARO GEORGE Director | Sale 10b5-1 | −21 | $140.78 | $3K | 5,743 |
| 2025-05-14 | MASSARO GEORGE Director | Sale 10b5-1 | −14 | $141.85 | $2K | 5,729 |
| 2025-05-14 | MASSARO GEORGE Director | Sale 10b5-1 | −7 | $143.77 | $1K | 5,722 |
Page 10 of 23 · 447 trades